Výsledky vyhledávání - "Salil Goorha"

Allogeneic CD34

Autor: Amanda, Lipsitt, Lisa, Beattie, Elaine, Harstead, Ying, Li, Salil, Goorha, Gabriela, Maron, Stephen, Gottschalk, Brandon, Triplett, Swati, Naik

Publikováno v: Pediatric bloodcancerREFERENCES.

Hematological toxicity (hematotoxicity) leading to peripheral cytopenias is a common long-term adverse effect following the use of CD19-chimeric antigen receptor (CD19-CAR) T-cell therapies. However, management remains unclear for patients whose cyto

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6de0c2af858b80c67be5c0619f392952
https://pubmed.ncbi.nlm.nih.gov/36565276

Zobrazit plný text záznamu

Allogeneic CD34+ Selected Hematopoietic Stem Cell Boost Following CAR T-cell Therapy in a Patient with Prolonged Cytopenia and Active Infection

Autor: Amanda Lipsitt, Lisa Beattie, Elaine Harstead, Ying Li, Salil Goorha, Gabriela Maron, Stephen Gottschalk, Brandon Triplett, Swati Naik

Hematological toxicity (hematotoxicity) is the most common long-term adverse effect following the use of CD19-chimeric antigen receptor (CD19-CAR) T-cell therapies. However, its management remains unclear. We present the case of a 21-year-old who rec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::577f8ff1f345a4c9cd0a0b978544bba3
https://doi.org/10.22541/au.166315142.27403264/v1

Zobrazit plný text záznamu

Risk factors for mortality and progression to severe COVID-19 disease in the Southeast region in the United States: A report from the SEUS Study Group

Autor: Morgan Walker, George E. Nelson, Athena L V Hobbs, Salil Goorha, Nicholas A Turner, Christina T. Fiske, Priyenka Thapa, Ronald M Beaulieu, Steven S Spires, Jeffrey Wright, John W. Gnann, Muhammad Sheikh, Imad Omer, Ryan K Dare

Publikováno v: Infection Control and Hospital Epidemiology

Objective:Identify risk factors that could increase progression to severe disease and mortality in hospitalized SARS-CoV-2 patients in the Southeast region of the United States.Design, setting, and participants:Multicenter, retrospective cohort inclu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdda513da7babed06ad245a2eba26d2e
https://doi.org/10.1017/ice.2020.1435

Zobrazit plný text záznamu

Using a standard implementation science framework to improve clinical trial enrollment for a community Tennessee oncology center

Autor: Neha M Jain, Philip Edward Lammers, Michael R. Savona, Travis John Osterman, Salil Goorha

Publikováno v: Journal of Clinical Oncology. 40:e18586-e18586

e18586 Background: Recommendations for clinical trial consideration are ubiquitous across all cancers. However, it is challenging to identify patients from underrepresented communities and offer them opportunities to enroll in clinical trials due to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4c975c4f45176c2914364b20b4e68547
https://doi.org/10.1200/jco.2022.40.16_suppl.e18586

Zobrazit plný text záznamu

Evaluating the Impact of the Addition of Cladribine to Standard Acute Myeloid Leukemia Induction Therapy

Autor: Salil Goorha, Nathan D. Seligson, Elizabeth L Mills, Joanna M Leonard, Athena L V Hobbs, Amy G Evans

Publikováno v: Annals of Pharmacotherapy. 52:439-445

Background: Treatment for acute myeloid leukemia (AML) has remained relatively unchanged over the past few decades. Although recent drug approvals have provided an increase in the number of treatment options in AML, further optimization of standard i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ac51f0efa80484f4f9cd8182fb1dfdb
https://doi.org/10.1177/1060028017749214

Zobrazit plný text záznamu

Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia

Publikováno v: Proceedings of the National Academy of Sciences. 106:12944-12949

Pediatric de novo acute myeloid leukemia (AML) is an aggressive malignancy with current therapy resulting in cure rates of only 60%. To better understand the cause of the marked heterogeneity in therapeutic response and to identify new prognostic mar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37e3997fba07ae56232e3ff99b51581c
https://doi.org/10.1073/pnas.0903142106

Zobrazit plný text záznamu

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

Autor: Mary V. Relling, Ina Radtke, Kevin Girtman, Charles G. Mullighan, Susan Mathew, Xiaoping Su, Elaine Coustan-Smith, Ching-Hon Pui, James R. Downing, Stanley Pounds, Christopher B. Miller, Sheila A. Shurtleff, Jing Ma, Salil Goorha, William E. Evans, James Dalton

Publikováno v: Nature. 446:758-764

Chromosomal aberrations are a hallmark of acute lymphoblastic leukaemia (ALL) but alone fail to induce leukaemia. To identify cooperating oncogenic lesions, we performed a genome-wide analysis of leukaemic cells from 242 paediatric ALL patients using

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d190f7d36bb8c8e1e24019822a8d441
https://doi.org/10.1038/nature05690

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání